Literature DB >> 24950368

Instability of bacteriophages in spray-dried trehalose powders is caused by crystallization of the matrix.

Dieter Vandenheuvel1, Joke Meeus2, Rob Lavigne3, Guy Van den Mooter4.   

Abstract

Spray drying is a valuable technique in pharmaceutical dosage formulation, capable of producing amorphous, spherical powders, suitable for pulmonary deposition and further downstream processing. In this study, we show that spray drying bacteriophages together with trehalose results in an amorphous powder matrix with high glass transition temperature (between 116 and 118°C), typical for amorphous trehalose. These powders are stable at low temperatures (4°C) and relative humidity (0%). However, high humidity causes crystallization of the amorphous matrix, destroying the embedded phages. Furthermore, storage at higher temperature (25°C) causes thermal instability of the embedded phages. The results show that storage conditions are important parameters to take into account in phage therapy development. The resulting particles are hollow spheres, with suitable aerodynamic diameters for deposition into the deep lungs. This opens possibilities to use these phage-containing powder formulations to tackle pulmonary infectious diseases, especially caused by antibiotic resistant pathogens.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bacteriophage; Crystallinity; Long-term Storage; Spray drying; Trehalose; Trehalose (PubChem CID: 7427)

Mesh:

Substances:

Year:  2014        PMID: 24950368     DOI: 10.1016/j.ijpharm.2014.06.026

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  15 in total

1.  Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections.

Authors:  Sharon S Y Leung; Thaigarajan Parumasivam; Fiona G Gao; Nicholas B Carrigy; Reinhard Vehring; Warren H Finlay; Sandra Morales; Warwick J Britton; Elizabeth Kutter; Hak-Kim Chan
Journal:  Pharm Res       Date:  2016-02-29       Impact factor: 4.200

2.  Storage stability of inhalable phage powders containing lactose at ambient conditions.

Authors:  Rachel Yoon Kyung Chang; Martin Wallin; Elizabeth Kutter; Sandra Morales; Warwick Britton; Jian Li; Hak-Kim Chan
Journal:  Int J Pharm       Date:  2019-01-31       Impact factor: 5.875

Review 3.  Phage therapy for respiratory infections.

Authors:  Rachel Yoon Kyung Chang; Martin Wallin; Yu Lin; Sharon Sui Yee Leung; Hui Wang; Sandra Morales; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2018-08-07       Impact factor: 15.470

4.  Microencapsulation of phages to analyze their demeanor in physiological conditions.

Authors:  Esra Acar Soykut; Emine Kübra Tayyarcan; Şefika Evran; İsmail Hakkı Boyacı; İbrahim Çakır; Maha Khaaladi; Sami Fattouch
Journal:  Folia Microbiol (Praha)       Date:  2019-02-12       Impact factor: 2.099

5.  Effects of storage conditions on the stability of spray dried, inhalable bacteriophage powders.

Authors:  Sharon S Y Leung; Thaigarajan Parumasivam; Fiona G Gao; Elizabeth A Carter; Nicholas B Carrigy; Reinhard Vehring; Warren H Finlay; Sandra Morales; Warwick J Britton; Elizabeth Kutter; Hak-Kim Chan
Journal:  Int J Pharm       Date:  2017-02-03       Impact factor: 5.875

6.  Prophylactic Delivery of a Bacteriophage Cocktail in Feed Significantly Reduces Salmonella Colonization in Pigs.

Authors:  Anisha M Thanki; Guillaume Mignard; Robert J Atterbury; Paul Barrow; Andrew D Millard; Martha R J Clokie
Journal:  Microbiol Spectr       Date:  2022-05-17

7.  Effect of storage temperature on the stability of spray dried bacteriophage powders.

Authors:  Sharon S Y Leung; Thaigarajan Parumasivam; An Nguyen; Thomas Gengenbach; Elizabeth A Carter; Nicholas B Carrigy; Hui Wang; Reinhard Vehring; Warren H Finlay; Sandra Morales; Warwick J Britton; Elizabeth Kutter; Hak-Kim Chan
Journal:  Eur J Pharm Biopharm       Date:  2018-02-24       Impact factor: 5.571

8.  Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate.

Authors:  Mellissa Gomez; Joseph McCollum; Hui Wang; Mani Ordoubadi; Chester Jar; Nicholas B Carrigy; David Barona; Isobel Tetreau; Michelle Archer; Alana Gerhardt; Chris Press; Christopher B Fox; Ryan M Kramer; Reinhard Vehring
Journal:  Int J Pharm       Date:  2020-12-02       Impact factor: 5.875

9.  Microparticle encapsulation of a tuberculosis subunit vaccine candidate containing a nanoemulsion adjuvant via spray drying.

Authors:  Mellissa Gomez; Michelle Archer; David Barona; Hui Wang; Mani Ordoubadi; Shabab Bin Karim; Nicholas B Carrigy; Zheng Wang; Joseph McCollum; Chris Press; Alana Gerhardt; Christopher B Fox; Ryan M Kramer; Reinhard Vehring
Journal:  Eur J Pharm Biopharm       Date:  2021-03-19       Impact factor: 5.589

10.  Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilization.

Authors:  Rachel Yoon Kyung Chang; Philip Chi Lip Kwok; Dipesh Khanal; Sandra Morales; Elizabeth Kutter; Jian Li; Hak-Kim Chan
Journal:  Bioeng Transl Med       Date:  2020-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.